Treating Older Patients with Myeloma: Adapting for Fit, Frail or In-Between
Tracks
-
| Tuesday, April 29, 2025 |
| 2:20 PM - 3:50 PM |
| Alsh |
Details
We will summarise data from recent frontline newly diagnosed myeloma studies for older patients including UKMRA MXIV trial, IMROZ and BENEFIT. We will also review the data on using immunotherapy including bi-specific antibody treatment in older patients and the session will give practical advice as to how to select patients and tailor these treatments to provide maximum benefit.
Speaker
Prof. Gordon Cook
Professor of Haematology
University of Leeds
Frailty score as a predictive biomarker: results from UKMRA Myeloma XIV FiTNEss study
2:25 PM - 2:45 PM
Prof. Salomon Manier
Md, Phd
Lille University Hospital
Management of elderly frail patients: a dexamethasone-sparing strategy
2:45 PM - 3:05 PM
Dr. Annabel McMillan
Consultant
Whittington Health NHS Trust
Bispecific antibody use in older patients with Multiple Myeloma
3:05 PM - 3:25 PM
Dr Rakesh Popat
Consultant Haematologist
University College London Hospitals NHS Foundation Trust
Discussion: how to use frailty in everyday clinic
3:25 PM - 3:45 PMChair
Ceri Bygrave
Consultant Haematologist
Cardiff and Vale UHB
